Matthew Buten's Net Worth
$6.8 Million
Who is Matthew Buten?
Matthew Buten has an estimated net worth of $6.8 Million. This is based on reported shares across multiple companies, which include Biohaven Pharmaceutical Holding Co Ltd., and Biohaven Ltd..
SEC CIK
Matthew Buten's CIK is 0001898799
Past Insider Trading and Trends
2022 was Matthew Buten's most active year for acquiring shares with 9 total transactions. Matthew Buten's most active month to acquire stocks was the month of September. 2022 was Matthew Buten's most active year for disposing of shares, totalling 7 transactions. Matthew Buten's most active month to dispose stocks was the month of September. 2022 saw Matthew Buten paying a total of $1,582,808.50 for 516,695 shares, this is the most they've acquired in one year. In 2022 Matthew Buten cashed out on 93,719 shares for a total of $1,000,099.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Biohaven Pharmaceutical Holding Co Ltd. No price found
Chief Financial OfficerMatthew Buten used to own units in Common Shares but no longer holds any shares there. In the year 2021 Matthew Buten acquired a total of 12,500 shares in Biohaven Pharmaceutical Holding Co Ltd., Matthew also disposed a total of 12,500 shares of Biohaven Pharmaceutical Holding Co Ltd. equalling to $1,788,657.13.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.18K |
$148.50 | -$917,284.50 |
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
∞
| 6.18K |
$137.81 | -$871,372.63 | 6.18K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biohaven Ltd. (BHVN) Snapshot price: $37
Chief Financial OfficerMatthew Buten owns 189,380 units of Common Shares which is worth $7,007,060.00. From 2022 to 2024 Matthew Buten acquired a total of 200,422 shares in Biohaven Ltd. at a cost of $2,082,802.50, Matthew also disposed a total of 11,042 shares of Biohaven Ltd. equalling to $82,815.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +13.64% | 22.73K |
$22.00 | $499,994.00 | 189.38K |
Oct 5
| |||
Form 4
| +600.34% | 142.86K |
$10.50 | $1,499,998.50 | 166.65K |
Oct 25
| |||
Form 4
|
∞
| 23.8K |
$6.94 | -$5.00 | 23.8K |
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||